In kidney transplant recipients, cardiovascular disease (CVD) is the leading cause of death. The relationship of kidney function with CVD outcomes in transplant recipients remains uncertain. We performed a post hoc analysis of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial to assess risk factors for CVD and mortality in kidney transplant recipients.
RECENT ARTICLES FROM THE MEDICAL LITERATURE IN KIDNEY TRANSPLANT. Shared by Dr. Alberto Reino Buelvas
Showing posts with label Cardiovascular Disease. Show all posts
Showing posts with label Cardiovascular Disease. Show all posts
Friday, May 18, 2012
Kidney Function and Risk of Cardiovascular Disease and Mortality in Kidney Transplant Recipients: The FAVORIT Trial
Kidney Function and Risk of Cardiovascular Disease and Mortality in Kidney Transplant Recipients: The FAVORIT Trial:
Subscribe to:
Posts (Atom)